St. Jude Medical
| Company type | Public |
|---|---|
Traded as | NYSE: STJ |
| Industry | Medical devices |
| Founded | Saint Paul, Minnesota, 1976 |
| Founder | Manuel A. Villafana |
| Defunct | January 4, 2017 |
| Fate | Acquired by Abbott Laboratories |
| Headquarters | Little Canada, Minnesota |
Area served | Worldwide |
Key people | Michael T. Rousseau, chairman, president and chief executive officer John C. Heinmiller, executive vice president Michael T. Rousseau, chief operating officer Donald J. Zurbay, vice president of finance and chief financial officer |
| Products | Cardiac rhythm management devices Implantable cardioverter-defibrillators Neuromodulation devices |
| Revenue | $5.6 billion (2014) [1] |
| Total assets | $10.207 billion (2014) [1] |
| Total equity | $4.2 billion (2014) [1] |
Number of employees | 18,000[2] |
| Website | www |
St. Jude Medical, Inc. was an American global medical device company headquartered in Little Canada, Minnesota, U.S., a suburb of Saint Paul. The company had more than 20 principal operations and manufacturing facilities worldwide with products sold in more than 100 countries.[3][4] Its major markets include the United States, Europe, Latin America and Asia-Pacific. The company was named after Jude the Apostle, the patron saint of lost causes.[4]
St. Jude Medical was founded in 1976 and went public in 1977,[4][5] and the company has been listed in the Fortune 500 every year since 2010.[6] The company was acquired by Abbott Laboratories in January 2017.[7][8]
Michael T. Rousseau served as the company's president and chief executive officer from 2016 until its acquisition by Abbott.[9]
- ^ a b c "St. Jude Medical Reports Fourth Quarter and Full-Year 2014 Results". BusinessWire. Retrieved December 30, 2015.
- ^ "Lisa Andrade Discusses St. Jude Medical's Medical Device Manufacturer of the Year Award". St. Jude Medical. Retrieved December 30, 2015.
- ^ "St. Jude Medical, Inc. 10-K". Securities and Exchange Commission. Retrieved 6 March 2014.
- ^ a b c "St. Jude Medical, Inc". International Directory of Company Histories. Retrieved 6 March 2014.
- ^ Fiedler, Terry (3 October 2002). "A perfectible heart; St. Jude Medical's mechanical heart valve was still the market standard 25 years after a Minnesota woman received the first implant in surgery at the U of M.". Star Tribune (Mpls.-St. Paul).
- ^ "Fortune 500: 445. St. Jude Medical". CNN Money. Retrieved 6 March 2014.
- ^ "Abbott to Buy St. Jude Medical in Deal Valued at About $25 Billion". Bloomberg.com. 28 April 2016.
- ^ "Abbott-St. Jude Combination: Why It Makes Sense". Bloomberg News.
- ^ "St. Jude Medical Announces Leadership Transition Plan". BusinessWire. September 9, 2015. Retrieved December 30, 2015.